Navigation Links
20 Mg Rimonabant Per Day may Help to Quit Smoking

Using rimonabant at a dose of 20 mg per day can help people quit smoking, can help them to remain abstinent, and can help prevent the weight gain that so often accompanies attempts at stopping smoking . The lower dose of 5mg, however, was not shown to be effective.

Smoking tobacco sends nicotine into the blood stream, and this chemical disrupts the endocannabinoid system, part of the hormonal control mechanism in the brain that controls energy balance and food intake.

Over time the body alters the nature of its energy mechanism to compensate for this effect. Stopping smoking removes the nicotine and once again disturbs the mechanism, adding to the withdrawal symptoms and leaving a person prone to put on weight.

One potential way of preventing this is to take a drug that blocks the receptor that is involved in nicotines action in the brain the cannabinoid 1 receptor.

These CB1 receptor antagonists could therefore form part of a therapeutic programme aimed at helping individuals quit smoking, although this drug has not yet been approved as a smoking cessation treatment in the USA or in Europe.

To see whether there was evidence that these receptor antagonists work two Cochrane Researchers, Kate Cahill who works at the Department of Primary Care in the University of Oxford and Michael Ussher who works at St Georges, University of London, searched the published and unpublished literature for relevant research projects.

They found three trials that involved a total of 1567 smokers and 1661 people who had recently quit smoking. Analysing the data showed that the effect of the drug depended on the dose used: Quitting with 20mg rimonabant: People given 20 mg rimonabant increased by 50% their odds of remaining abstinent compared with those on placebo. Smokers who had quit while using 20mg rimonabant increased by 50% their odds of staying abstinent if they continued taking eithe r 5mg or 20mg rimonabant, compared with those who moved to placebo treatment after quitting.

Quitting with 5mg rimonabant: People who wanted to quit appeared to gain no benefit from 5 mg rimonabant treatment. Furthermore the people who did manage to quit using this lower dose were equally likely to remain abstinent whether they continued with rimonabant treatment or moved to a placebo.

Weight gain: Weight gain appeared to be significantly lower in people who quit while using 20 mg rimonabant than those taking either 5 mg rimonabant or placebo.

The differences in weight between the groups appeared to be maintained through longest follow-up. This beneficial effect was more evident in overweight or obese smokers than in those of normal weight.

From the preliminary data that we found it appears that 20mg rimonabant may significantly increase a persons likelihood of quitting and may also reduce the amount of weight that they gain, says Cahill.


Related medicine news :

1. UK Reports Psychiatric Reactions to Weight-loss Drug Rimonabant
2. New hope on the Horizon for People Wishing to Quit Smoking
3. Cancers of Colon & Rectum linked to Cigarette Smoking
4. Smoking a greater risk than HIV? Yes say health experts!!!!
5. Kick Smoking with Nicotine Drink
6. Smoking spreads Cancer
7. Prescription Drug - Helps People Stop Smoking
8. Quit Smoking
9. Smoking can depreciate intellegence
10. Smoking Delays Pregnancy
11. Smoking Linked To Low Infant Birth Weight
Post Your Comments:

(Date:10/13/2015)... ... (PRWEB) October 13, 2015 ... its 2015 annual meeting and corresponding events Oct. 29-31 in ... seminars; a luncheon featuring keynote speaker Air Force Gen. Paul ... the Community Heroes Award Night, which recognizes individuals and groups ...
(Date:10/13/2015)... , ... October 13, 2015 , ... Vision Group Holdings, ... of San Diego, California. With brands including The LASIK Vision Institute and TLC Laser ... it the nationwide leader in laser vision correction. , Global Laser Vision will continue ...
(Date:10/13/2015)... Nashville, Tennessee (PRWEB) , ... October 13, 2015 ... ... owned leader of anesthesia and pain management services, today announced its partnership with ... the partnership integrates data from disparate systems and organizes the data into an ...
(Date:10/13/2015)... ... October 13, 2015 , ... Symposium Chairman, Dr. Rod J. Rohrich ... Cosmetic Symposium to be held March 2nd and 3rd, 2016. The annual meeting, along ... surgeons and cosmetic physicians from around the world. , Key topics at this year's ...
(Date:10/13/2015)... ST. LOUIS and CHENNAI, India (PRWEB) , ... October 13, 2015 ... ... the development of advanced camera solutions, today announced See3CAM_CU40, the industry’s first ... stand-alone MIPI CSI-2 module. See3CAM_CU40, a new member of e-con’s See3CAM family of UVC ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... ) has ... European markets for Meniscal Repair - 16 Countries ... ) has announced the addition of ... Repair - 16 Countries (2010-2021)" report to ... ( ) has announced the addition of ...
(Date:10/13/2015)... , Oct. 13, 2015   Vigilant Biosciences, Inc. ... that aid in the early detection and intervention of ... Vigilant,s founder and CEO, Matthew H.J. Kim , ... which recognizes an entrepreneur who has made extraordinary contributions ... life sciences industry in the leadership of a company ...
(Date:10/13/2015)... , Oct. 13, 2015  EndoChoice Holdings, Inc. ... third quarter 2015 financial results on Thursday, November 5, ... . --> . ... Thursday, November 5, 2015 at 9:00 a.m. ET to ... for domestic callers and (412) 317-5469 for international callers. ...
Breaking Medicine Technology: